CooperCompanies forecasts FY26 non-GAAP EPS USD 4.51-4.55
COO•CooperCompanies raises fiscal 2026 guidance
The Cooper Companies raised fiscal 2026 guidance, updated Sept. 9, projecting total revenue of $4.23-$4.25 billion.
- Organic revenue growth outlook set at 2%-3%, led by CooperSurgical at 4%-5% versus CooperVision at 1%-2%.
- Non-GAAP EPS forecast at $4.51-$4.55, implying Q4 non-GAAP EPS of $1.05-$1.09.
- Q4 revenue expected at $1.06-$1.08 billion, including CooperVision $692-$706 million and CooperSurgical $364-$374 million.
- Free cash flow objective set above $2.2 billion.
